| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr11:76032200-76034200 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
| 2 |
chr11:76032800-76034000 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
| 3 |
chr11:76032800-76034200 |
Enhancers |
Left Ventricle |
heart
|
| 4 |
chr11:76033400-76034000 |
Bivalent Enhancer |
Rectal Mucosa Donor 29 |
rectum
|
| 5 |
chr11:76033400-76034200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
| 6 |
chr11:76033400-76034200 |
Enhancers |
Placenta |
Placenta
|
| 7 |
chr11:76033400-76035000 |
Enhancers |
Hela-S3 |
cervix
|
| 8 |
chr11:76033400-76035200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 9 |
chr11:76033400-76038600 |
Weak transcription |
Spleen |
Spleen
|
| 10 |
chr11:76033600-76034000 |
Bivalent Enhancer |
H9 Cell Line |
embryonic stem cell
|
| 11 |
chr11:76033600-76034000 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 12 |
chr11:76033600-76034000 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 13 |
chr11:76033600-76034200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
| 14 |
chr11:76033600-76034200 |
Bivalent Enhancer |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 15 |
chr11:76033600-76034200 |
Bivalent Enhancer |
Primary T regulatory cells fromperipheralblood |
blood
|
| 16 |
chr11:76033600-76034200 |
Enhancers |
Adipose Nuclei |
Adipose
|
| 17 |
chr11:76033600-76034200 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
| 18 |
chr11:76033600-76034200 |
Enhancers |
Pancreas |
Pancrea
|
| 19 |
chr11:76033600-76034400 |
Weak transcription |
Fetal Heart |
heart
|
| 20 |
chr11:76033600-76035000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 21 |
chr11:76033600-76035400 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
| 22 |
chr11:76033600-76035400 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|
| 23 |
chr11:76033600-76035400 |
Enhancers |
K562 |
blood
|
| 24 |
chr11:76033600-76035600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
| 25 |
chr11:76033600-76038400 |
Weak transcription |
Right Atrium |
heart
|
| 26 |
chr11:76033600-76040200 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
| 27 |
chr11:76033800-76034000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
| 28 |
chr11:76033800-76034000 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
| 29 |
chr11:76033800-76034000 |
Bivalent Enhancer |
Primary mononuclear cells fromperipheralblood |
Blood
|
| 30 |
chr11:76033800-76034000 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
| 31 |
chr11:76033800-76034200 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
| 32 |
chr11:76033800-76034200 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
| 33 |
chr11:76033800-76034200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 34 |
chr11:76033800-76034200 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
| 35 |
chr11:76033800-76034400 |
Enhancers |
NHEK |
skin
|
| 36 |
chr11:76033800-76034600 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
| 37 |
chr11:76033800-76034600 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
| 38 |
chr11:76033800-76034800 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
| 39 |
chr11:76033800-76035200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
| 40 |
chr11:76033800-76035200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 41 |
chr11:76033800-76040000 |
Weak transcription |
Fetal Lung |
lung
|
